List of Excipients in API HYDROMORPHONE HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing HYDROMORPHONE HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| SpecGx LLC | HYDROMORPHONE HYDROCHLORIDE | hydromorphone hydrochloride | 0406-3308 | ANHYDROUS LACTOSE | |
| SpecGx LLC | HYDROMORPHONE HYDROCHLORIDE | hydromorphone hydrochloride | 0406-3308 | BUTYLATED HYDROXYTOLUENE | |
| SpecGx LLC | HYDROMORPHONE HYDROCHLORIDE | hydromorphone hydrochloride | 0406-3308 | CELLULOSE ACETATE | |
| SpecGx LLC | HYDROMORPHONE HYDROCHLORIDE | hydromorphone hydrochloride | 0406-3308 | FERRIC OXIDE RED | |
| SpecGx LLC | HYDROMORPHONE HYDROCHLORIDE | hydromorphone hydrochloride | 0406-3308 | FERROSOFERRIC OXIDE | |
| SpecGx LLC | HYDROMORPHONE HYDROCHLORIDE | hydromorphone hydrochloride | 0406-3308 | HYPROMELLOSE 2910 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing HYDROMORPHONE HYDROCHLORIDE
Detailed excipient profiles for HYDROMORPHONE HYDROCHLORIDE
Excipient focus: ACETONE
HYDROMORPHONE HYDROCHLORIDE drug variants containing ACETONE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | hydromorphone hydrochloride | 31722-119 |
| Ascent Pharmaceuticals Inc | hydromorphone hydrochloride | 43602-266 |
| XLCare Pharmaceuticals Inc | hydromorphone hydrochloride | 72865-168 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing ACETONE
Excipient focus: AMMONIO METHACRYLATE COPOLYMER TYPE A
HYDROMORPHONE HYDROCHLORIDE drug variants containing AMMONIO METHACRYLATE COPOLYMER TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | hydromorphone hydrochloride | 0574-0293 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing AMMONIO METHACRYLATE COPOLYMER TYPE A
Excipient focus: ANHYDROUS LACTOSE
HYDROMORPHONE HYDROCHLORIDE drug variants containing ANHYDROUS LACTOSE
HYDROMORPHONE HYDROCHLORIDE drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BUTYLATED HYDROXYTOLUENE
HYDROMORPHONE HYDROCHLORIDE drug variants containing BUTYLATED HYDROXYTOLUENE
HYDROMORPHONE HYDROCHLORIDE drug variants not containing BUTYLATED HYDROXYTOLUENE
Excipient focus: CELLULOSE ACETATE
HYDROMORPHONE HYDROCHLORIDE drug variants containing CELLULOSE ACETATE
HYDROMORPHONE HYDROCHLORIDE drug variants not containing CELLULOSE ACETATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
HYDROMORPHONE HYDROCHLORIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
HYDROMORPHONE HYDROCHLORIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID MONOHYDRATE
HYDROMORPHONE HYDROCHLORIDE drug variants containing CITRIC ACID MONOHYDRATE
HYDROMORPHONE HYDROCHLORIDE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: D&C RED NO. 30
HYDROMORPHONE HYDROCHLORIDE drug variants containing D&C RED NO. 30
HYDROMORPHONE HYDROCHLORIDE drug variants not containing D&C RED NO. 30
Excipient focus: D&C YELLOW NO. 10
HYDROMORPHONE HYDROCHLORIDE drug variants containing D&C YELLOW NO. 10
HYDROMORPHONE HYDROCHLORIDE drug variants not containing D&C YELLOW NO. 10
Excipient focus: ETHYLCELLULOSE
HYDROMORPHONE HYDROCHLORIDE drug variants containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | hydromorphone hydrochloride | 0574-0293 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing ETHYLCELLULOSE
Excipient focus: FD&C BLUE NO. 1
HYDROMORPHONE HYDROCHLORIDE drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | hydromorphone hydrochloride | 0574-0293 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C RED NO. 40
HYDROMORPHONE HYDROCHLORIDE drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | hydromorphone hydrochloride | 17856-0386 |
| Lohxa | hydromorphone hydrochloride | 70166-250 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
HYDROMORPHONE HYDROCHLORIDE drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Trigen Laboratories LLC | hydromorphone hydrochloride | 13811-703 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
HYDROMORPHONE HYDROCHLORIDE drug variants containing FERRIC OXIDE RED
HYDROMORPHONE HYDROCHLORIDE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
HYDROMORPHONE HYDROCHLORIDE drug variants containing FERRIC OXIDE YELLOW
HYDROMORPHONE HYDROCHLORIDE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
HYDROMORPHONE HYDROCHLORIDE drug variants containing FERROSOFERRIC OXIDE
HYDROMORPHONE HYDROCHLORIDE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GLYCERIN
HYDROMORPHONE HYDROCHLORIDE drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | hydromorphone hydrochloride | 0527-1873 |
| Ascent Pharmaceuticals Inc | hydromorphone hydrochloride | 43602-001 |
| Purdue Pharma LP | hydromorphone hydrochloride | 59011-451 |
| American Health Packaging | hydromorphone hydrochloride | 60687-566 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing GLYCERIN
Excipient focus: HYPROMELLOSE
HYDROMORPHONE HYDROCHLORIDE drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | hydromorphone hydrochloride | 31722-119 |
| Ascent Pharmaceuticals Inc | hydromorphone hydrochloride | 43602-266 |
| XLCare Pharmaceuticals Inc | hydromorphone hydrochloride | 72865-168 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
HYDROMORPHONE HYDROCHLORIDE drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Trigen Laboratories LLC | hydromorphone hydrochloride | 13811-703 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
HYDROMORPHONE HYDROCHLORIDE drug variants containing HYPROMELLOSE 2910
HYDROMORPHONE HYDROCHLORIDE drug variants not containing HYPROMELLOSE 2910
Excipient focus: ISOPROPYL ALCOHOL
HYDROMORPHONE HYDROCHLORIDE drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | hydromorphone hydrochloride | 31722-119 |
| Ascent Pharmaceuticals Inc | hydromorphone hydrochloride | 43602-266 |
| XLCare Pharmaceuticals Inc | hydromorphone hydrochloride | 72865-168 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTIC ACID
HYDROMORPHONE HYDROCHLORIDE drug variants containing LACTIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | hydromorphone hydrochloride | 0409-1283 |
| Hospira Inc | hydromorphone hydrochloride | 0409-2552 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing LACTIC ACID
Excipient focus: LACTOSE
HYDROMORPHONE HYDROCHLORIDE drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | hydromorphone hydrochloride | 16590-774 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
HYDROMORPHONE HYDROCHLORIDE drug variants containing LACTOSE MONOHYDRATE
HYDROMORPHONE HYDROCHLORIDE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LACTOSE, ANHYDROUS
HYDROMORPHONE HYDROCHLORIDE drug variants containing LACTOSE, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| STAT Rx USA LLC | hydromorphone hydrochloride | 16590-942 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing LACTOSE, ANHYDROUS
Excipient focus: MAGNESIUM STEARATE
HYDROMORPHONE HYDROCHLORIDE drug variants containing MAGNESIUM STEARATE
HYDROMORPHONE HYDROCHLORIDE drug variants not containing MAGNESIUM STEARATE
Excipient focus: MANNITOL
HYDROMORPHONE HYDROCHLORIDE drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | hydromorphone hydrochloride | 0574-0293 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing MANNITOL
Excipient focus: METHYLPARABEN
HYDROMORPHONE HYDROCHLORIDE drug variants containing METHYLPARABEN
HYDROMORPHONE HYDROCHLORIDE drug variants not containing METHYLPARABEN
Excipient focus: POLYETHYLENE GLYCOL
HYDROMORPHONE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL
HYDROMORPHONE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
HYDROMORPHONE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | hydromorphone hydrochloride | 23635-408 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
HYDROMORPHONE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | hydromorphone hydrochloride | 0574-0293 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 7000000
HYDROMORPHONE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL 7000000
| Company | Ingredient | NDC |
|---|---|---|
| Trigen Laboratories LLC | hydromorphone hydrochloride | 13811-703 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL 7000000
Excipient focus: POLYETHYLENE GLYCOLS
HYDROMORPHONE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | hydromorphone hydrochloride | 54868-6387 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYETHYLENE OXIDE 200000
HYDROMORPHONE HYDROCHLORIDE drug variants containing POLYETHYLENE OXIDE 200000
HYDROMORPHONE HYDROCHLORIDE drug variants not containing POLYETHYLENE OXIDE 200000
Excipient focus: POLYSORBATE 80
HYDROMORPHONE HYDROCHLORIDE drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | hydromorphone hydrochloride | 31722-119 |
| Ascent Pharmaceuticals Inc | hydromorphone hydrochloride | 43602-266 |
| XLCare Pharmaceuticals Inc | hydromorphone hydrochloride | 72865-168 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing POLYSORBATE 80
Excipient focus: POVIDONE
HYDROMORPHONE HYDROCHLORIDE drug variants containing POVIDONE
HYDROMORPHONE HYDROCHLORIDE drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
HYDROMORPHONE HYDROCHLORIDE drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | hydromorphone hydrochloride | 0574-0293 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing POVIDONE K30
Excipient focus: POVIDONES
HYDROMORPHONE HYDROCHLORIDE drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | hydromorphone hydrochloride | 54868-6387 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing POVIDONES
Excipient focus: PROPYLENE GLYCOL
HYDROMORPHONE HYDROCHLORIDE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | hydromorphone hydrochloride | 0574-0293 |
| ATLANTIC BIOLOGICALS CORP | hydromorphone hydrochloride | 17856-0386 |
| Lohxa | hydromorphone hydrochloride | 70166-250 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
HYDROMORPHONE HYDROCHLORIDE drug variants containing PROPYLPARABEN
HYDROMORPHONE HYDROCHLORIDE drug variants not containing PROPYLPARABEN
Excipient focus: RASPBERRY
HYDROMORPHONE HYDROCHLORIDE drug variants containing RASPBERRY
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | hydromorphone hydrochloride | 17856-0386 |
| Lohxa | hydromorphone hydrochloride | 70166-250 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing RASPBERRY
Excipient focus: SACCHARIN SODIUM ANHYDROUS
HYDROMORPHONE HYDROCHLORIDE drug variants containing SACCHARIN SODIUM ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | hydromorphone hydrochloride | 17856-0386 |
| Lohxa | hydromorphone hydrochloride | 70166-250 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing SACCHARIN SODIUM ANHYDROUS
Excipient focus: SILICON DIOXIDE
HYDROMORPHONE HYDROCHLORIDE drug variants containing SILICON DIOXIDE
HYDROMORPHONE HYDROCHLORIDE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM CHLORIDE
HYDROMORPHONE HYDROCHLORIDE drug variants containing SODIUM CHLORIDE
HYDROMORPHONE HYDROCHLORIDE drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM CITRATE
HYDROMORPHONE HYDROCHLORIDE drug variants containing SODIUM CITRATE
HYDROMORPHONE HYDROCHLORIDE drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
HYDROMORPHONE HYDROCHLORIDE drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | hydromorphone hydrochloride | 0409-1283 |
| Hospira Inc | hydromorphone hydrochloride | 0409-2552 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LACTATE
HYDROMORPHONE HYDROCHLORIDE drug variants containing SODIUM LACTATE
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | hydromorphone hydrochloride | 0409-1283 |
| Hospira Inc | hydromorphone hydrochloride | 0409-2552 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing SODIUM LACTATE
Excipient focus: SODIUM METABISULFITE
HYDROMORPHONE HYDROCHLORIDE drug variants containing SODIUM METABISULFITE
HYDROMORPHONE HYDROCHLORIDE drug variants not containing SODIUM METABISULFITE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
HYDROMORPHONE HYDROCHLORIDE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Aurolife Pharma LLC | hydromorphone hydrochloride | 13107-107 |
| Bryant Ranch Prepack | hydromorphone hydrochloride | 71335-0723 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SORBITOL
HYDROMORPHONE HYDROCHLORIDE drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | hydromorphone hydrochloride | 17856-0386 |
| Lohxa | hydromorphone hydrochloride | 70166-250 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing SORBITOL
Excipient focus: STEARIC ACID
HYDROMORPHONE HYDROCHLORIDE drug variants containing STEARIC ACID
HYDROMORPHONE HYDROCHLORIDE drug variants not containing STEARIC ACID
Excipient focus: SUCROSE
HYDROMORPHONE HYDROCHLORIDE drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | hydromorphone hydrochloride | 0527-1873 |
| Ascent Pharmaceuticals Inc | hydromorphone hydrochloride | 43602-001 |
| Purdue Pharma LP | hydromorphone hydrochloride | 59011-451 |
| American Health Packaging | hydromorphone hydrochloride | 60687-566 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing SUCROSE
Excipient focus: TALC
HYDROMORPHONE HYDROCHLORIDE drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | hydromorphone hydrochloride | 0574-0293 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
HYDROMORPHONE HYDROCHLORIDE drug variants containing TITANIUM DIOXIDE
HYDROMORPHONE HYDROCHLORIDE drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
HYDROMORPHONE HYDROCHLORIDE drug variants containing TRIACETIN
HYDROMORPHONE HYDROCHLORIDE drug variants not containing TRIACETIN
Excipient focus: TRIETHYL CITRATE
HYDROMORPHONE HYDROCHLORIDE drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | hydromorphone hydrochloride | 0574-0293 |
| >Company | >Ingredient | >NDC |
HYDROMORPHONE HYDROCHLORIDE drug variants not containing TRIETHYL CITRATE
Excipient focus: WATER
HYDROMORPHONE HYDROCHLORIDE drug variants containing WATER
HYDROMORPHONE HYDROCHLORIDE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
